*Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina

†Wills Eye Hospital, Mid Atlantic Retina, Thomas Jefferson University, Philadelphia, Pennsylvania; and

‡Cleveland Clinic, Cole Eye Institute, Cleveland, Ohio.

Reprint requests: Dilraj S Grewal, MD, Department of Ophthalmology, Duke University Medical Center, 2351 Erwin Road, Durham, North Carolina 27701; e-mail: [email protected]

J.D. Deaner, D.S. Grewal, S.K. Srivastava, and S. Sharma have the following disclosures related to the submitted work, Eyepoint: Consultant. J.D. Deaner, D.S. Grewal, S.K. Srivastava, and S. Sharma have the following disclosure related to the submitted work, Eyepoint: Consultant. J.D. Deaner has the following disclosures outside of the submitted work, EyePoint: Consultant, Alimera: Consultant. G.J. Jaffe has the following disclosures outside of the submitted work, Regeneron: Consultant, Eyetech: Consultant, and Novartis: Consultant. D.S. Grewal has the following disclosures outside of the submitted work, Allergan: Consultant, and Alimera: Consultant. S.K. Srivastava has the following disclosures outside of the submitted work, Consultant for Allergan, Bausch and Lomb, Clearside, Regeneron, Novartis, RegenxBio, Santen, Zeiss, and Gilead; and Research support from Allergan, Eyepoint, Santen, and Regeneron. S. Sharma has the following disclosures outside of the submitted work, Consultant for Alimera, Allergan, Bausch & Lomb, Clearside, Genentech/Roche, and Regeneron; and Research Support from Gilead, Genentech/Roche, Santen, and IONIS.